Medicus Pharma (MDCX) Stock Price, News & Analysis

Company Overview

Medicus Pharma Ltd. is a life sciences company focused on acquiring, developing and commercializing innovative therapeutic and medical device technologies. Its activities are centered primarily on wound care, dermatology and related areas of medical treatment.

The company’s portfolio includes Natrox® Oxygen Wound Therapy, a device designed to deliver continuous topical oxygen to the wound site. The technology is intended to support the treatment of chronic and hard-to-heal wounds and may be used in clinical and home-care settings, subject to applicable regulatory approvals.

Medicus Pharma serves healthcare markets through the commercialization of its technologies and partnerships with medical professionals and distribution networks. Publicly available information about the company’s broader operations, geographic reach and leadership is limited.

Key Stats

• Today's Range: $3.14 to $3.67
• 50-Day Range: $3.58 to $17.70
• 52-Week Range: $3.14 to $139.00
• Volume: 65,899 shs
• Average Volume: 83,583 shs
• Market Capitalization: $207.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $450.00
• Consensus Rating: Moderate Buy

Medicus Pharma Stock Analysis - MarketRank™

Medicus Pharma scored higher than 53% of companies evaluated by MarketBeat, and ranked 507th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medicus Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Medicus Pharma has a consensus price target of $450.00, representing about 13,413.5% upside from its current price of $3.33.

Amount of Analyst Coverage

Medicus Pharma has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Medicus Pharma are expected to grow in the coming year, from ($0.73) to ($0.55) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medicus Pharma is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medicus Pharma is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.35% of the float of Medicus Pharma has been sold short.

Short Interest Ratio / Days to Cover

Medicus Pharma has a short interest ratio ("days to cover") of 0.94, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medicus Pharma has recently decreased by 26.24%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medicus Pharma does not currently pay a dividend.

Dividend Growth

Medicus Pharma does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.33

News Sentiment

Medicus Pharma has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Medicus Pharma this week, compared to 5 articles on an average week.

Search Interest

Only 7 people have searched for MDCX on MarketBeat in the last 30 days. This is a decrease of -53% compared to the previous 30 days.

MarketBeat Follows

Only 11 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medicus Pharma insiders have not sold or bought any company stock.

Percentage Held by Insiders

8.10% of the stock of Medicus Pharma is held by insiders.

Percentage Held by Institutions

Medicus Pharma has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:MDCX
• Previous Symbol: NASDAQ:MDCX
• CIK: 1997296
• Web: www.medicuspharma.com
• Phone: (610) 540-7515
• Fax: N/A
• Employees: 16
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Medicus Pharma: $450.00
• High Price Target: $450.00
• Low Price Target: $450.00
• Potential Upside/Downside: +13,619.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.46)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$35.46 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -3,137.84%
• Return on Assets: -263.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.57
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 63,180,000
• Free Float: 58,063,000
• Market Cap: $207.23 million
• Optionable: N/A
• Beta: 0.30